NATUREX : Number of shares and voting rights as at 30 November 2014

le
0

Number of shares and voting rights
Article L.233-8-II of Commercial Law (Code de commerce) and
Article 223-16 of the General Regulation of the French Financial Markets Authority
(AMF - Autorité des Marchés Financiers)

Press release
Avignon, December 4th 2014

 


28.11.2014


 

Total number of outstanding shares forming the capital
- 9,194,933 ordinary shares under ISIN FR0000054694
- 1,292 shares issued from stock-options under ISIN FR0000054694
9,196,225
Number of shares with double voting rights 871,541
Total number of gross voting rights 10,067,766
Number of shares without voting rights
- 9,014 bearer shares in the frame of the liquidity contract
- 9,014
Total number of exercisable voting rights* 10,058,752

*Real number of voting rights = total number of voting rights - number of shares without voting rights

 

If you would like to receive financial information about Naturex by e-mail, go to: www.naturex.com

 

  • Financial schedule
    - Annual revenue
    - Annual results
    3 February 2015
    31 March 2015
  • Upcoming events
    - SFAF analysts meeting (Paris) 2 April 2015

Naturex has been listed since October 1996 on Euronext in Paris. Segment B

  Total number of shares comprising the share capital: 9.196.225 (November 2014)
ISIN FR0000054694

NATUREX is a component of the CACT. Enternext CAC PEA-PME 150. CAC Small & Mid. CAC Small. Gaïa Index.
Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).
Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility. Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.

TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR Symbol: NTUXY

 

About Naturex

Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage. Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food. nutraceutical. pharmaceutical and cosmetic industries.

Naturex's head office is based in Avignon. The company employs 1.600 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 16 sites in Europe. Morocco. the United States. Brazil. Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.

  • Contacts
Carole Alexandre
Investor Relations
Tel.: +33 (0)4 90 23 78 28
c.alexandre@naturex.com
 
 
Anne Catherine Bonjour
Actus Finance Press Relations
Tel.: +33 (0)1 53 67 36 93
acbonjour@actus.fr
Thierry-Bertrand Lambert
Chief Financial Officer
Tel.: +33 (0)4 90 23 96 89
t.b.lambert@naturex.com

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :
-
Communiqué intégral et original au format PDF :
http://www.actusnews.com/documents_communiques/ACTUS-0-38139-cp-naturex_041214.pdf

Si le fichier PDF ne s'affiche pas ou pour le télécharger, cliquez ici.

Pour consulter le fichier PDF en intégralité, cliquez ici.

Pour visualiser les documents au format PDF, vous pouvez télécharger gratuitement Acrobat Reader XI.


Valeur associée
  Libellé Bourse Dernier Var. Vol.
Vous devez être membre pour ajouter des commentaires.
Devenez membre, ou connectez-vous.
Aucun commentaire n'est disponible pour l'instant